Managed Care, Drug Benefits and Mortality: An Analysis of the Elderly
45 Pages Posted: 27 Jul 2006 Last revised: 20 Nov 2022
Date Written: January 2004
Abstract
We seek to investigate whether managed health care can affect mortality, and if so, through which mechanisms. We estimate the impact of Medicare+Choice (M+C), Medicare's managed care program, on elderly mortality, using a county-level panel from 1993 to 2000. We control for endogenous M+C penetration rates with county fixed effects and instrumental variables. We construct instruments using the identification created by the fact that M+C payment rates are based on 3 to 8 year lagged fee-for-service (FFS) costs in the county. We find that enrollment in managed care without prescription drug coverage significantly increases mortality while enrollment in managed care with drug coverage has no significant impact, both relative to FFS. The impact of managed care penetration on mortality from heart disease appears to follow a similar pattern. The estimates suggest that a 10-percentage point increase in M+C non-drug coverage would cause 51,000 additional deaths among the aged population in 2000.
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
-
The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
-
The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
-
"Napsterizing" Pharmaceuticals: Access, Innovation, and Consumer Welfare
By James W. Hughes, Michael J. Moore, ...
-
The Cost of Us Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions
By Thomas A. Abbott and John A. Vernon
-
Intellectual Property and Marketing
By Darius N. Lakdawalla, Tomas Philipson, ...
-
The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output